All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation or HealthTree for Multiple Myeloma.

The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your Multiple Myeloma Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The Multiple Myeloma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Multiple Myeloma Hub cannot guarantee the accuracy of translated content. The Multiple Myeloma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.
2017-07-30T20:09:48.000Z

59th ASH Annual Meeting & Exposition: abstract submission deadline 2nd August

Jul 30, 2017
Share:

Bookmark this article

The 59th American Society of Hematology (ASH) Meeting and Exposition will take place in Atlanta, Georgia, USA, from 9th – 12th December 2017. Abstract submission is due to close on Wednesday 2nd August , 11:59 p.m. (Pacific Time); with the call for late-breaking abstract submissions from 20th – 30th October. Registration opened for ASH members on July 19th and will open to non-members on 9thAugust, 11:00 a.m. Eastern Time; the registration deadline is 1st November. To learn more about the meeting, you can download the preliminary program or visit the official conference website.

The meeting is described by ASH as, “The premier event in malignant and non-malignant hematology”, and will showcase the best scientific research in these fields. The conference will include standard oral sessions of the best selected abstracts, poster sessions, as well as ‘scientific spotlight sessions’ and the opportunity to ‘meet the scientist’. Smaller ‘special interest sessions’ have been scheduled targeting both scientists and practicing hematologists, covering topics such as ‘How to Get published in a Peer-Reviewed Journal’ as well as a special education session on ‘New ASH Clinical Practice Guidelines on Venous Thromboembolism (VTE)’, and a networking reception for female hematologists. Such sessions will contribute to an all-round educational experience, with numerous training opportunities available, in addition to the opportunity to meet with leading scientific researchers and clinicians from a global community of more than 25,000 attendees.

The Multiple Myeloma Hub will be covering key highlights from ASH 2017 including oral sessions, late breaking abstracts, video interviews with key thought leaders and educational sessions, with a focus on the latest MM research that impacts clinical practice.

 

More about...

Your opinion matters

As a result of this content, I commit to reviewing the CARTITUDE clinical program to guide my understanding of cilta-cel in clinical practice.
27 votes - 5 days left ...

Newsletter

Subscribe to get the best content related to multiple myeloma delivered to your inbox